Success Metrics

Clinical Success Rate
50.0%

Based on 1 completed trials

Completion Rate
50%(1/2)
Active Trials
1(20%)
Results Posted
0%(0 trials)
Terminated
1(20%)

Phase Distribution

Ph not_applicable
2
40%
Ph phase_1
1
20%
Ph phase_4
1
20%
Ph early_phase_1
1
20%

Phase Distribution

2

Early Stage

0

Mid Stage

1

Late Stage

Phase Distribution5 total trials
Early Phase 1First-in-human
1(20.0%)
Phase 1Safety & dosage
1(20.0%)
Phase 4Post-market surveillance
1(20.0%)
N/ANon-phased studies
2(40.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

33.3%

1 of 3 finished

Non-Completion Rate

66.7%

2 ended early

Currently Active

1

trials recruiting

Total Trials

5

all time

Status Distribution
Active(1)
Completed(1)
Terminated(2)
Other(1)

Detailed Status

Withdrawn1
unknown1
Recruiting1
Completed1
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
5
Active
1
Success Rate
50.0%
Most Advanced
Phase 4

Trials by Phase

Early Phase 11 (20.0%)
Phase 11 (20.0%)
Phase 41 (20.0%)
N/A2 (40.0%)

Trials by Status

withdrawn120%
unknown120%
recruiting120%
completed120%
terminated120%

Recent Activity

1 active trials
Showing 5 of 5
completedphase_4

Use of Topical Olive Oil Cream for Prophylaxis Against Acute Radiodermatitis in Breast Cancer Patients

NCT05285943
recruitingphase_1

Testing Use of Topical Imipramine in Reducing Ultraviolet B Induced Microvesicle Particle Release in Photosensitive Subjects

NCT04520217
terminatednot_applicable

Topical Palm Tocotrienols on Skin Biophysical Properties

NCT05787743
withdrawnearly_phase_1

Photodynamic Therapy and Microvesicles

NCT03960125
unknownnot_applicable

Effects of Oral and Topical Sea Buckthorn Oil Treatments on Skin Aging

NCT00767156

Clinical Trials (5)

Showing 5 of 5 trials
NCT05285943Phase 4

Use of Topical Olive Oil Cream for Prophylaxis Against Acute Radiodermatitis in Breast Cancer Patients

Completed
NCT04520217Phase 1

Testing Use of Topical Imipramine in Reducing Ultraviolet B Induced Microvesicle Particle Release in Photosensitive Subjects

Recruiting
NCT05787743Not Applicable

Topical Palm Tocotrienols on Skin Biophysical Properties

Terminated
NCT03960125Early Phase 1

Photodynamic Therapy and Microvesicles

Withdrawn
NCT00767156Not Applicable

Effects of Oral and Topical Sea Buckthorn Oil Treatments on Skin Aging

Unknown

All 5 trials loaded

Drug Details

Intervention Type
OTHER
Total Trials
5